Status:
COMPLETED
The Effect of Vasopressor on Pressure Injury Development
Lead Sponsor:
Koç University
Conditions:
Vasopressor Adverse Reaction
Pressure Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Vasopressors are life-saving agents that increase mean arterial pressure. The pharmacodynamic features of these agents and previous studies suggest that vasopressors may be an essential ri...
Detailed Description
There is a need for studies in which vasopressor drugs are discussed in detail and the risk factors that may cause pressure injury development in patients. Therefore, this study aims to examine vasopr...
Eligibility Criteria
Inclusion
- The sample consisted of all:
- Medical and surgical patients over 18 who do not have pressure injury upon admission
- Received one or more vasopressor agent infusions (norepinephrine, epinephrine, phenylephrine, dopamine, adrenaline, dobutamine) for at least 48 hours during their stay in the intensive care unit
Exclusion
- patients less than 18 years old
- less than 48 hours stay in intensive care unit
- did not receive ant vasospressor agents
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT06163352
Start Date
May 1 2023
End Date
September 1 2023
Last Update
December 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Koç University
Istanbul, None Selected, Turkey (Türkiye), 34010